Ann: International Presentation of BIT225 COVID-19 Data, page-16

The old HIV argument to come first is quite ironic in light of the delay of any significant progress on C19, as HIV has been over 20 years in the making with numerous 'successfu'l human trials, but not much to show for it.

I would have thought that the once in a lifetime pandemic and the urgency it created should have produced a new, quick entry point to stardom.

But no, betting on the HIV thesis, 20 years+ is certainly makes the potential of success this year...... a not long now event.

Either disease will do. Both will be better.

Today's PR and the trading looks like an arranged opportunity to sell out.

Too long now.